ArticleCurrent microbiology2016
In Vitro Antibiofilm Activity of an Exopolysaccharide from the Marine Thermophilic Bacillus licheniformis T14.
Article in Current microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 90 citations in OpenAlex.
- Statistical investigation of marine bacterial extracellular polysaccharides: deciphering the interplay among environmental adaptation, species distribution, and biomedical potential.Marine life science & technology · 2026Review
- Comparative Optimization of Culture Media for Enhanced β-Glucan Production byFood science & nutrition · 2025Article
- Production and biological activities of exopolysaccharides synthesized by thermophilic bacilli isolated from hot springs in Türkiye.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Investigating the multi-targeted pharmacological profile of an exopolysaccharide fromArchives of medical science : AMS · 2025Article
- Characterization of Exopolysaccharides fromMicroorganisms · 2024Article
- Article
- Marine versus Non-Marine Bacterial Exopolysaccharides and Their Skincare Applications.Marine drugs · 2023Review
- Promising Materials in the Fight against Healthcare-Associated Infections: Antibacterial Properties of Chitosan-Polyhedral Oligomeric Silsesquioxanes Hybrid Hydrogels.Journal of functional biomaterials · 2023Article
- Review
- Recent advances in the biological activities of microbial exopolysaccharides.World journal of microbiology & biotechnology · 2023Review
- Anti-Bacterial Adhesion on Abiotic and Biotic Surfaces of the Exopolysaccharide from the Marine Bacillus licheniformis B3-15.Marine drugs · 2023Article
- Anti-Biofilm Activity of a Hyaluronan-like Exopolysaccharide from the MarineMarine drugs · 2022Article
- Molecular Characterization and Biocompatibility of Exopolysaccharide Produced by Moderately Halophilic BacteriumPolymers · 2022Article
- Hydrating Capabilities of the Biopolymers Produced by the Marine ThermophilicMaterials (Basel, Switzerland) · 2022Article
- The role of microplastics biofilm in accumulation of trace metals in aquatic environments.World journal of microbiology & biotechnology · 2022Review
- Biological Functions of Exopolysaccharides from Lactic Acid Bacteria and Their Potential Benefits for Humans and Farmed Animals.Foods (Basel, Switzerland) · 2022Review
- Fucose-containing bacterial exopolysaccharides: Sources, biological activities, and food applications.Food chemistry: X · 2022Article
- Recent Antimicrobial Responses of Halophilic Microbes in Clinical Pathogens.Microorganisms · 2022Review
- Characterization and Biological Activity of a Novel Exopolysaccharide Produced byMicroorganisms · 2021Article
- Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments.Journal, genetic engineering & biotechnology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of antibiofilm strategies is of major interest in contrasting bacterial pathogenic biofilms. A novel fructose and fucose rich exopolysaccharide (EPS1-T14) produced by the recently described thermophilic Bacillus licheniformis T14, isolated from a shallow hydrothermal vent of Panarea Island (Eolian Island, Italy), was evaluated for its effects on biofilm formation by multiresistant clinical strains of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus. The antibiofilm activity of EPS1-T14 was assessed by microtiter plate assays and visualized by confocal laser scanning microscopic images. EPS1-T14, with molecular weight of 1000 kDa, reduced biofilm formation on abiotic surfaces without affecting bacterial vitality. The novel EPS1-T14 is a water-soluble, noncytotoxic exopolymer able to prevent biofilm formation and its use may represent a promising therapeutic strategy for combating bacterial biofilm-associated infections. EPS1-T14 as antiadhesive biomolecule could be useful for novel prospective in medical and nonmedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.